Rv3854c - p.Asp144Glu
Drug resistance types
14 Sensitive
0 RR-TB
3 HR-TB
2 MDR-TB
0 Pre-XDR-TB
0 XDR-TB
5 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage4.9 | 15 |
| lineage4.8.1;lineage4.9;lineage6.1.3;lineage6.3 | 1 |
| La1.6;La3;M.canetti;lineage4.2.2 | 1 |
| La1.6;La3;M.canetti;lineage3;lineage4.2;lineage4.3.4;lineage4.9;lineage6.3 | 1 |
| lineage4.9;lineage6.3 | 1 |
| lineage1.1.2 | 1 |
| lineage4.8 | 1 |
| lineage4.2;lineage4.6.3;lineage4.9.1 | 1 |
| lineage4.1.1.1 | 1 |
| lineage4.2;lineage4.6.3;lineage4.9 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 24 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | SRR13837441 | Sensitive | lineage4.9 | None | SRR13837442 | Sensitive | lineage4.9 | None | SRR13861592 | Other | lineage4.9 | None | SRR13837443 | Sensitive | lineage4.9 | None | SRR13861279 | Sensitive | lineage4.9 | None | ERR6358991 | HR-TB | lineage4.8.1;lineage4.9;lineage6.1.3;lineage6.3 | None | SRR13861496 | Other | lineage4.9 | None | SRR13837952 | Sensitive | lineage4.9 | None | SRR11662696 | MDR-TB | La1.6;La3;M.canetti;lineage4.2.2 | None | SRR13861593 | Other | lineage4.9 | None | SRR13837554 | Sensitive | lineage4.9 | None | ERR4798406 | MDR-TB | La1.6;La3;M.canetti;lineage3;lineage4.2;lineage4.3.4;lineage4.9;lineage6.3 | None | ERR212121 | HR-TB | lineage4.9;lineage6.3 | None | SRR13837941 | Sensitive | lineage4.9 | None | SRR29772516 | Sensitive | lineage1.1.2 | None | ERR2229537 | Sensitive | lineage4.8 | dk | ERR3283026 | HR-TB | lineage4.2;lineage4.6.3;lineage4.9.1 | None | ERR718453 | Sensitive | lineage4.1.1.1 | th | SRR13837440 | Sensitive | lineage4.9 | None | SRR13861278 | Other | lineage4.9 | None | SRR13861516 | Other | lineage4.9 | None | SRR13837963 | Sensitive | lineage4.9 | None | SRR13837439 | Sensitive | lineage4.9 | None | ERR5311097 | Sensitive | lineage4.2;lineage4.6.3;lineage4.9 | None |
|---|
